These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 31792870)

  • 1. Evaluating the Concordance of Clinician Antiretroviral Prescribing Practices and HIV-ASSIST, an Online Clinical Decision Support Tool.
    Ramirez JA; Maddali MV; Budak JZ; Li JZ; Lampiris H; Shah M
    J Gen Intern Med; 2020 May; 35(5):1498-1503. PubMed ID: 31792870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Validation of HIV-ASSIST, an Online, Educational, Clinical Decision Support Tool to Guide Patient-Centered ARV Regimen Selection.
    Maddali MV; Mehtani NJ; Converse C; Kapoor S; Pham P; Li JZ; Shah M
    J Acquir Immune Defic Syndr; 2019 Oct; 82(2):188-194. PubMed ID: 31513553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of clinician preference and HIV-ASSIST recommendations in antiretroviral therapy decision-making: A single center experience from Turkiye.
    Akbulut I; Odemis I; Atalay S; Inkaya AC
    Int J STD AIDS; 2024 May; 35(6):430-437. PubMed ID: 38261725
    [No Abstract]   [Full Text] [Related]  

  • 4. New Strategies in Clinical Guideline Delivery: Randomized Trial of Online, Interactive Decision Support Versus Guidelines for Human Immunodeficiency Virus Treatment Selection by Trainees.
    Ramirez JA; Maddali MV; Nematollahi S; Li JZ; Shah M
    Clin Infect Dis; 2021 May; 72(9):1608-1614. PubMed ID: 32211758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of nevirapine- versus efavirenz-containing regimens in HIV-infected Thai children.
    Lapphra K; Vanprapar N; Chearskul S; Phongsamart W; Chearskul P; Prasitsuebsai W; Chokephaibulkit K
    Int J Infect Dis; 2008 Nov; 12(6):e33-8. PubMed ID: 18573672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic drug monitoring of antiretrovirals for people with HIV.
    Kredo T; Van der Walt JS; Siegfried N; Cohen K
    Cochrane Database Syst Rev; 2009 Jul; (3):CD007268. PubMed ID: 19588422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
    Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
    BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of early mortality and effectiveness of antiretroviral therapy in TB-HIV patients from Brazil.
    Demitto FO; Schmaltz CAS; Sant'Anna FM; Arriaga MB; Andrade BB; Rolla VC
    PLoS One; 2019; 14(6):e0217014. PubMed ID: 31170171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between antiretroviral prescribing patterns and treatment guidelines in treatment-naive HIV-1-infected US veterans (1992-2004).
    Holodniy M; Hornberger J; Rapoport D; Robertus K; MaCurdy TE; Lopez J; Volberding P; Deyton L
    J Acquir Immune Defic Syndr; 2007 Jan; 44(1):20-9. PubMed ID: 17091020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polypharmacy and risk of antiretroviral drug interactions among the aging HIV-infected population.
    Holtzman C; Armon C; Tedaldi E; Chmiel JS; Buchacz K; Wood K; Brooks JT;
    J Gen Intern Med; 2013 Oct; 28(10):1302-10. PubMed ID: 23605401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with mortality among persistently viraemic triple-antiretroviral-class-experienced patients receiving antiretroviral therapy in the HIV Outpatient Study (HOPS).
    Palella FJ; Armon C; Buchacz K; Chmiel JS; Novak RM; D'Aquila RT; Brooks JT;
    J Antimicrob Chemother; 2014 Oct; 69(10):2826-34. PubMed ID: 24942257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretroviral Stewardship in a Pediatric HIV Clinic: Development, Implementation and Improved Clinical Outcomes.
    Hsu AJ; Neptune A; Adams C; Hutton N; Agwu AL
    Pediatr Infect Dis J; 2016 Jun; 35(6):642-8. PubMed ID: 26906161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical manifestations and treatment outcomes in HIV-1-infected children receiving antiretroviral therapy in Karachi, Pakistan.
    Mir F; Qamar FN; Baig-Ansari N; Abro AG; Abbas SQ; Kazi MA; Rizvi A; Zaidi AK
    J Infect Dev Ctries; 2014 Apr; 8(4):519-25. PubMed ID: 24727519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual Therapy Treatment Strategies for the Management of Patients Infected with HIV: A Systematic Review of Current Evidence in ARV-Naive or ARV-Experienced, Virologically Suppressed Patients.
    Baril JG; Angel JB; Gill MJ; Gathe J; Cahn P; van Wyk J; Walmsley S
    PLoS One; 2016; 11(2):e0148231. PubMed ID: 26849060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of raltegravir in HIV-1 management.
    Rokas KE; Bookstaver PB; Shamroe CL; Sutton SS; Millisor VE; Bryant JE; Weissman SB
    Ann Pharmacother; 2012 Apr; 46(4):578-89. PubMed ID: 22496475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Could widespread use of combination antiretroviral therapy eradicate HIV epidemics?
    Velasco-Hernandez JX; Gershengorn HB; Blower SM
    Lancet Infect Dis; 2002 Aug; 2(8):487-93. PubMed ID: 12150848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral therapy in geriatric HIV patients: the GEPPO cohort study.
    Nozza S; Malagoli A; Maia L; Calcagno A; Focà E; De Socio G; Piconi S; Orofino G; Cattelan AM; Celesia BM; Gervasi E; Guaraldi G;
    J Antimicrob Chemother; 2017 Oct; 72(10):2879-2886. PubMed ID: 28605493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV update: emerging clinical evidence and a review of recommendations for the use of highly active antiretroviral therapy.
    Kress KD
    Am J Health Syst Pharm; 2004 Oct; 61 Suppl 3():S3-14; quiz S15-6. PubMed ID: 15503932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dolutegravir-lamivudine as initial therapy in HIV-1 infected, ARV-naive patients, 48-week results of the PADDLE (Pilot Antiretroviral Design with Dolutegravir LamivudinE) study.
    Cahn P; Rolón MJ; Figueroa MI; Gun A; Patterson P; Sued O
    J Int AIDS Soc; 2017 May; 20(1):21678. PubMed ID: 28537061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short communication: Lower baseline CD4 count is associated with a greater propensity toward virological failure in a cohort of South African HIV patients.
    Costiniuk CT; Sigal A; Jenabian MA; Nijs P; Wilson D
    AIDS Res Hum Retroviruses; 2014 Jun; 30(6):531-4. PubMed ID: 24803320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.